Beaumont Financial Advisors, LLC

Position in JNJ — Johnson & Johnson

CIK 1957394 NEEDHAM, MA

Position in JNJ

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$28,245,527

+$105,106 QoQ

Shares Held

111,216

-3.4% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

3.72%

of 13F equity value

Holder Rank

#618

of 4,676 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Beaumont Financial Advisors, LLC holds $40,048,849 across 7 Drug Manufacturers - General names. JNJ ranks #1 (70.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	111,216	$28,245,527
2	LLY	ELI LILLY & Co	4,760	$5,709,287
3	MRK	Merck & Co., Inc.	15,195	$1,952,557
4	ABBV	AbbVie Inc.	7,660	$1,927,562
5	AMGN	Amgen Inc	4,130	$1,495,555
6	BMY	Bristol Myers Squibb Co	8,606	$495,877
7	GILD	Gilead Sciences, Inc.	1,761	$222,484

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$28,245,527	111,216	-3.4%	Shares	Sole	2026-08-04
2026-03-31	$28,140,421	115,122	-2.6%	Shares	Sole	2026-05-05
2025-12-31	$24,464,594	118,215	-5.6%	Shares	Sole	2026-01-16
2025-09-30	$23,216,067	125,208	-0.2%	Shares	Sole	2025-10-23
2025-06-30	$19,165,084	125,467	-0.6%	Shares	Sole	2025-07-16
2025-03-31	$20,930,500	126,209	-0.0%	Shares	Sole	2025-05-12
2024-12-31	$18,257,118	126,242	+0.2%	Shares	Sole	2025-01-17
2024-09-30	$20,411,943	125,953	-1.8%	Shares	Sole	2024-10-09
2024-06-30	$18,739,612	128,213	-2.9%	Shares	Sole	2024-07-24
2024-03-31	$20,886,774	132,036	+0.4%	Shares	Sole	2024-05-10
2023-12-31	$20,608,331	131,481	+0.4%	Shares	Sole	2024-01-31
2023-09-30	$20,387,052	130,896	-3.0%	Shares	Sole	2023-11-01
2023-06-30	$22,327,985	134,896	-0.4%	Shares	Sole	2023-08-02
2023-03-31	$20,998,005	135,471	-3.1%	Shares	Sole	2023-05-08
2022-12-31	$24,689,840	139,767	—	Shares	Sole	2023-01-25
No filing history on record for this holder in this stock.